Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries.

Research Grants show all

NIH3

Patents show all

Cephalon has 1 licensable patents.
1,141Applications1,090Issued

Clinical Trials show all

55Phase 252Phase 319Phase 114Phase 411Phase 1/Phase 212Other

SEC Filings show all

8-K25110-Q4710-K10

Overview

Total FundingEmployeesLast Funding DateStatus
1001-5000Operating